This inventor holds 4 USPTO granted patents. Top assignee: Roussel Uclaf. Active years: 1980-1988.
Location History:
- Montreuil, FR (1980 - 1988)
- Montreuil-Sous-Bois, FR (1988)
Company Filing History:
Years Active: 1980-1988
Title: Claude Rettien: Innovator in Pharmaceutical Chemistry
Introduction
Claude Rettien is a notable inventor based in Montreuil, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 4 patents, Rettien's work focuses on novel compounds with potential therapeutic applications.
Latest Patents
Rettien's latest patents include groundbreaking research on tetrahydrobenz(c,d)indoles. These compounds have been identified for their pharmaceutical use, showcasing antianoxic, hypotensive, antihypertensive, and dopaminergic agonist activity. Another significant patent involves 2,3-dihydro indoles, which includes racemic mixtures and optical isomers of 4-morpholinyl-1H-indoles. These compounds are designed to activate neurons and protect them against ischemic or anoxic aggressions.
Career Highlights
Claude Rettien is associated with Roussel Uclaf, a company known for its commitment to pharmaceutical innovation. His work has contributed to advancements in drug development and therapeutic solutions. Rettien's expertise in synthesizing complex chemical compounds has positioned him as a key figure in his field.
Collaborations
Rettien has collaborated with notable colleagues such as Jean-Claude Gasc and Lucien Nedelec. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical products.
Conclusion
Claude Rettien's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an innovator in the field. His work continues to influence the development of new therapeutic agents that may improve patient outcomes.